BioSpace News Archive

Biotech Bay

BioMarin to Participate in Bank of America 2023 Health Care Conference

BioMarin Pharmaceutical Inc. announced that Brian Mueller, Executive Vice President, Chief Financial Officer of BioMarin will present at the Bank of America 2023 Health Care Conference on Wednesday, May 10, 2023 at 3:40pm PT, in Las Vegas, NV.

May 4, 2023
·
1 min read
BioCapital

Novavax to Participate in the BofA Securities 2023 Health Care Conference

Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, announced that it will participate in the BofA Securities 2023 Health Care Conference.

May 4, 2023
·
1 min read
Business

Heron Therapeutics to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

Heron Therapeutics, Inc. announced that the company will host a conference call and live webcast on Thursday, May 11, 2023 at 4:30 p.m. ET to report first quarter 2023 financial results and discuss recent business highlights.

May 4, 2023
·
2 min read
Business

Biolase to Report First Quarter 2023 Results on May 11, 2023

BIOLASE, Inc. announced that it will release first quarter 2023 financial and operating results on Thursday, May 11, 2023, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.

May 4, 2023
·
2 min read
Pharm Country

Trevi Therapeutics to Report Q1 2023 Financial Results and Provide a Corporate Update on May 11, 2023

Trevi Therapeutics, Inc. announced that senior management will host a conference call and live audio webcast on Thursday, May 11, 2023, at 4:30 p.m. ET, to provide a corporate update and review the Company’s financial results for the first quarter ended March 31, 2023.

May 4, 2023
·
2 min read
Business

Insulet Reports First Quarter 2023 Revenue Increase of 21% Year-Over-Year (23% Constant Currency1)

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced financial results for the three months ended March 31, 2023.

May 4, 2023
·
13 min read
Business

Rocket Pharmaceuticals Reports First Quarter 2023 Financial Results and Highlights Recent Progress

Rocket Pharmaceuticals, Inc. reported financial results for the quarter ending March 31, 2023, and updates from the Company’s key pipeline developments, business operations and upcoming milestones.

May 4, 2023
·
14 min read
Business

DermTech Reports First-Quarter 2023 Financial Results

Covered lives increased to 126 million Cash runway through the third quarter of 2024 DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics platform, reported its first-quarter 2023 financial results.

May 4, 2023
·
9 min read
Policy

Nucleix’s Bladder EpiCheck® Receives FDA 510(k) Clearance for Monitoring of Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence

Nucleix has received 510 clearance from the U.S. Food and Drug Administration to market Bladder EpiCheck® for use as a non-invasive method for surveillance of tumor recurrence in patients previously diagnosed with non-muscle invasive bladder cancer, in conjunction with cystoscopy.

May 4, 2023
·
4 min read
Business

Pro-Dex, Inc. Announces Fiscal 2023 Third Quarter and Nine-Month Results

PRO-DEX, INC. announced financial results for its fiscal 2023 third quarter ended March 31, 2023.

May 4, 2023
·
8 min read